DBV Technologies (DBVT) Return on Capital Employed (QoQ) (2021 - 2026)

DBV Technologies (DBVT) Return on Capital Employed (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 DBV Technologies 267.50 Mn 92.60 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -844.00
Mar 31, 2026 4,395.00
Dec 31, 2025 3,356.00
Sep 30, 2025 9,381.00
Jun 30, 2025 39,045.00
Mar 31, 2025 -40,490.00
Dec 31, 2024 -9,786.00
Sep 30, 2024 -5,374.00
Jun 30, 2024 -2,943.00
Mar 31, 2024 -948.00
Dec 31, 2023 826.00
Sep 30, 2023 -623.00
Jun 30, 2023 -449.00
Mar 31, 2023 -445.00
Dec 31, 2022 -1,410.00
Sep 30, 2022 1,564.00
Jun 30, 2022 3,489.00
Mar 31, 2022 -342.00
Dec 31, 2021 508.00
Sep 30, 2021 -661.00